Cargando…

P15-06. Brighton collaboration viral vector vaccines safety working group (V3SWG): maximizing the comparability and value of safety data from HIV vaccine trials

Detalles Bibliográficos
Autores principales:	Chen, RT, Excler, J, Laderoute, MP, Mahy, BW, Hendry, MP, Via, CM, Compingbutra, AA, Gidudu, J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767701/ http://dx.doi.org/10.1186/1742-4690-6-S3-P207

Ejemplares similares

Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines
por: Gurwith, Marc, et al.
Publicado: (2020)

The Brighton Collaboration standardized templates for collection of key information for benefit-risk assessment of vaccines by technology (BRAVATO; formerly V3SWG)
por: Chen, Robert T., et al.
Publicado: (2021)

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines
por: Kochhar, Sonali, et al.
Publicado: (2020)

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines
por: Condit, Richard C, et al.
Publicado: (2020)

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines
por: Kochhar, Sonali, et al.
Publicado: (2020)

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus
por: Hernandez, Libia Milena, et al.
Publicado: (2022)

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines
por: Kim, Denny, et al.
Publicado: (2020)

We should abandon the Brighton Collaboration criteria for vaccine-associated anaphylaxis
por: Hurley, Sadhbh, et al.
Publicado: (2022)

The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform
por: Volkmann, Ariane, et al.
Publicado: (2021)

Brighton Conference
Publicado: (1983)

Brighton Conference
Publicado: (1983)

Brighton rock /
por: Greene, Graham, 1904-1991
Publicado: (1943)

The Brighton Hospitals
Publicado: (1904)

The Climate of Brighton
Publicado: (1860)

Brighton Charities
Publicado: (1889)

Rooks in Brighton
Publicado: (1919)

P06-01. Developing a sponsor-initiated clinical guidance for AIDS vaccine research
por: Priddy, F, et al.
Publicado: (2009)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2020)

The Indian Hospitals at Brighton
Publicado: (1915)

Hospitals and the War: Brighton
Publicado: (1914)

La Conférence de Brighton
Publicado: (1983)

Brighton parque de atracciones /
por: Greene, Graham, 1904-1991
Publicado: (1982)

The Sussex County Hospital, Brighton
por: Bourchier, E. F.
Publicado: (1890)

The Medico-Sociological Section at Brighton
por: Ryle, Reginald John
Publicado: (1913)

The Lady Chichester Hospital, Brighton
Publicado: (1913)

Improved safety and effectiveness of imaging predicted for MR mammography
por: Laderoute, M P
Publicado: (2004)

Safety of Interchanging the Live Attenuated MAV/06 Strain and OKA Strain Varicella Vaccines in Children
por: Kang, Hyun Mi, et al.
Publicado: (2023)

The New GPI-Anchored Protein, SwgA, Is Involved in Nitrogen Metabolism in the Pathogenic Filamentous Fungus Aspergillus fumigatus
por: Samalova, Marketa, et al.
Publicado: (2023)

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine
por: Estephan, Lila, et al.
Publicado: (2023)

P06-06. Capacity building for HIV vaccine trials in Africa through South-South collaboration
por: Mpendo, J, et al.
Publicado: (2009)

As Made at the Pavilion General Hospital, Brighton
por: Maurice, G. T. K.
Publicado: (1918)

Brighton and Its Three Climates, &c.
Publicado: (1843)

A Brighton Infirmary for Indian Troops
Publicado: (1914)

Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000–2015()
por: Lei, Jiayao, et al.
Publicado: (2018)

Meeting abstracts from the 5th International Clinical Trials Methodology Conference (ICTMC 2019): Brighton, UK. 06-09 October 2019
Publicado: (2019)

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273)
por: Leav, Brett, et al.
Publicado: (2022)

Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccination: A Sex-Stratified Analysis of the VAERS Database Using Brighton Collaboration Criteria
por: Liguori, Valerio, et al.
Publicado: (2023)

The Annual Meeting of the B.M.A. at Brighton
Publicado: (1913)

The Public Health: Interviews with Local Authorities: Brighton
Publicado: (1924)

Queueing Theory and COVID-19 Prevention: Model Proposal to Maximize Safety and Performance of Vaccination Sites
por: Di Pumpo, Marcello, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s6sgcp4os56jo05450bjm8ncmo